ACCEL Lite: Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

Apr 13, 2023   |  Alison Bailey, MD, FACC; Sun Moon Kim, MD, FACC; Mirvat A. Alasnag, MBBS, FACC

Podcast

Font Size
A
A
A

What are the practical considerations when determining the duration of antiplatelet regimens following PCI?

In this interview, Mirvat Alasnag FACP, FACC, FSCAI, FSCCT, and Sun Moon Kim MD, FSCAI, FACC, discuss Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

Related References:

  1. ACC 2016 guidelines
  2. MASTERDAPT Trial



Clinical Topics: Prevention, Heart Failure and Cardiomyopathies, Pulmonary Hypertension and Venous Thromboembolism

Keywords: ACCELLite, Aspirin, Cardiovascular Diseases, Secondary Prevention, Clopidogrel


< Back to Listings